Health Canada begins a priority review of semaglutide 2.4 mg, a weekly treatment by Novo Nordisk for MASH, a liver disease ...

For patients with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis, semaglutide is associated with ...

Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...

Research revealed that medications widely used for diabetes and obesity may offer significant benefits for patients with ...

A new study reveals that semaglutide, a common diabetes medication, may effectively treat fatty liver disease, offering hope ...

Arizona's largest privately owned primary care provider, is opening a new clinic in Avondale, continuing its mission to make healthcare more accessible, convenient, and patient-centered. The clinic is ...

Cantata Health Solutions, a leading provider of healthcare technology solutions for behavioral health and human services providers, announces Arize MAT, a new Medication-Assisted Treatment (MAT) ...

Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...

Semaglutide - the active ingredient in medications like Ozempic and WeGovy - is only FDA approved for Type-2 diabetes, but ...

Semaglutide is the key component of weight loss and diabetes drugs like Ozempic and Wegovy, and an international team of ...

Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...